Tamarack Advisers, LP View Ray, Inc. Transaction History

Tamarack Advisers, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.66 - $3.97 $798,000 - $1.19 Million	-300,000 Reduced 75.0%	100,000 $364,000
Q2 2022 Aug 16, 2022	SELL	$2.42 - $4.05 $484,000 - $810,000	-200,000 Reduced 33.33%	400,000 $1.06 Million
Q1 2022 May 11, 2022	SELL	$3.45 - $5.83 $2.07 Million - $3.5 Million	-600,000 Reduced 50.0%	600,000 $2.35 Million
Q4 2021 Feb 14, 2022	SELL	$4.89 - $7.59 $1.96 Million - $3.04 Million	-400,000 Reduced 25.0%	1,200,000 $6.61 Million
Q3 2021 Nov 12, 2021	SELL	$5.18 - $7.41 $2.07 Million - $2.96 Million	-400,000 Reduced 20.0%	1,600,000 $11.5 Million
Q2 2021 Aug 13, 2021	SELL	$3.94 - $6.75 $1.77 Million - $3.04 Million	-450,000 Reduced 18.37%	2,000,000 $13.2 Million
Q1 2021 May 12, 2021	BUY	$4.03 - $7.25 $9.87 Million - $17.8 Million	2,450,000 New	2,450,000 $10.7 Million

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Tamarack Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Tamarack Advisers, LP with notifications on news.